Sex Hormone Binding Globulin (SHBG) is a transport protein made primarily by the liver that binds to sex hormones like testosterone and estrogen in the bloodstream. When hormones are bound to SHBG, they’re temporarily inactive; only “free” (unbound) hormones are biologically active. Because SHBG controls how much hormone is free vs. bound, it acts like a gatekeeper and buffer system for hormone activity.

An SHBG test helps estimate how much testosterone and estradiol are free and active by showing how much hormone may be “tied up” in bound form. Low SHBG often means a higher free fraction (more active hormone), while high SHBG can reduce the free fraction even if total levels look normal. For best interpretation, compare SHBG with total testosterone, free testosterone, and symptoms.

Low SHBG commonly reflects insulin resistance, obesity, metabolic syndrome, or fatty liver-related metabolic stress. When insulin is chronically elevated or androgen exposure is high, the liver tends to produce less SHBG. That can increase free testosterone and estrogen activity even when total hormones appear “in range.” Persistently low SHBG can be an early metabolic warning sign before type 2 diabetes develops.

In women, low SHBG can increase the free (active) fraction of androgens and estrogens, contributing to irregular periods, acne, oily skin, excess facial hair, and mood changes. This pattern is often seen in polycystic ovary syndrome (PCOS), especially when low SHBG is combined with elevated testosterone levels. Low SHBG may also point toward metabolic syndrome, which commonly overlaps with PCOS.

In men, low SHBG can mean more free testosterone and estrogen are circulating, potentially contributing to acne, hair loss, and longer-term prostate concerns. A common misconception is that “normal total testosterone” always equals normal hormone effects. If SHBG is low, free hormone activity may be higher than expected, or fluctuating, which can still drive symptoms tied to metabolic strain.

High SHBG binds testosterone and estradiol more tightly, reducing the free (active) fractions available to tissues. This can “starve” cells of hormone signaling even when total testosterone looks normal, leading to symptoms like low libido, fatigue, low energy, mood changes, and difficulty building muscle. High SHBG commonly reflects hyperthyroidism, aging, or exposure to higher estrogen states (including estrogen therapy).

SHBG reference ranges typically span about 10–80 nmol/L, though “optimal” varies by sex, age, and metabolic health. In general, values in the mid-to-upper portion of the reference range often align with better insulin sensitivity and steadier hormone availability. Because SHBG is a buffer system, the best target is the level that matches your symptoms, total testosterone, and free testosterone rather than a single universal number.

SHBG can rise with age (notably in men), pregnancy (due to estrogen), oral estrogen use, and higher thyroid hormone states. It can fall with androgens, growth hormone, glucocorticoids, insulin resistance, and obesity. Because SHBG is made in the liver, liver disease or chronic illness can also shift production. These factors can meaningfully change free testosterone and estrogen availability without changing totals.

SHBG is produced in the liver, so it can reflect liver function and metabolic strain. The context notes SHBG often drops with fatty liver disease, which frequently coexists with insulin resistance and metabolic syndrome. Low SHBG may therefore be a clue that liver and metabolic systems are under pressure. Tracking SHBG over time can support a broader picture of metabolic health and liver-related hormone regulation.

SHBG is best interpreted alongside total testosterone, free testosterone, and symptoms to understand true hormone bioavailability. In hormone therapy, SHBG can influence how much administered hormone becomes free and active, helping guide dosing to keep levels safe and effective. If SHBG is high, free hormone may be low despite normal totals; if SHBG is low, free hormone may be higher than expected - both can affect symptom response.